Home  >  Pharma People
Pharma People
+ Font Resize -

ABLE announces its new executive council team, Shrikumar Suryanarayan takes over as president

Our Bureau, Bengaluru
Thursday, April 5, 2018, 08:00 Hrs  [IST]

Association of Biotechnology Led Enterprises (ABLE) has elected its new Executive Council, led by Shrikumar Suryanarayan, chairman, Sea6Energy, as its president. He takes over from Dr P M Murali, managing director Evolva Biotech and taken charge on April 1, 2018. The Association’s newly elected 12-member executive committee will hold office for the next three years, up to March 31, 2021.

Biocon and ABLE’s founder, Kiran Mazumdar-Shaw, will continue in her capacity as the non-executive chairperson.

The core member representation of the executive council has G S Krishnan, managing director, Novozymes South Asia, as its vice president. Dr Goutam Das, director, Goutam Das Consultancy, will service as general secretary. Dr Anand Anandkumar, managing director, Bugworks Research will be the new treasurer.

The other executive council members are Dr KK Narayanan, former president, ABLE, Dr Murali, Dr Vijay Chandru, CMD, Strand Life Sciences, also former president, ABLE, Dr Raja Mugasimangalam managing director, Genotypic Technologies, Sujay Shetty partner and leader, pharmaceuticals and life sciences, PwC India. Ravi Bhola, partner, KNS Partners & Intellectual Property Attorneys, Dr Shriram Ragavan, vice president, Evolva Biotech and Dr Jayashree Aiyar, vice president and head, Discovery-Biology, Syngene International.

The new team will congregate for its first meeting on April 5, 2018 at the Bangalore Bioinnovation Centre.

Suryanarayan has served as vice president ABLE for the past three years and has been involved for over a decade with the Association serving as its Honorary Director-General.  In his professional capacity, he was the President, R&D head, Biocon, after which he founded a startup, Sea6Energy, that is housed in National Centre for Biological Sciences, Bengaluru which is engaged in bio-stimulants and bio-fuels, with operations in Indonesia.

“Biotechnology touches many important sectors of our economy and has a major role to play in improving the prosperity and health of the people of our country. ABLE will continue its role to facilitate the development of this sector and to work with the government to ensure that India can become a world leader in this sector,” said Suryanarayan.


Post Your commentsPOST YOUR COMMENT
* Name :     
* Email :    
  Website :  
S.Anand Kumar Oct 16, 2018 10:38 AM
Congratulations on your being elected as the President of ABLE.
Hopefully under your leadership the endowment donated by erstwhile AstraZeneca Research Foundation, will be used as agreed upon in the Memorandum of Understanding signed by the then President of ABLE, Dr (Prof). Vijay Chandru. No information is disclosed as to how the endowment amount is invested and what it is worth now. Best wishes and Greetings.
S.Anand Kumar
Ipe_2019_150x 60
Copyright © 2016 Saffron Media Pvt. Ltd |